Sector dividends Dianthus Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 01:45:02 2024-09-18 pm EDT			5-day change	1st Jan Change
25.86 ^USD	-0.48%		-6.51%	+149.90%

Aug. 09	Wedbush Adjusts Dianthus Therapeutics' PT to $36 From $38, Keeps Outperform Rating	MT
Aug. 08	Dianthus Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Yield (Y)	Yield (Y+1)	P/E ratio	Price to Book	EV / Sales	EV / EBITDA	EV / EBIT	Capi. ($)
VERTEX PHARMACEUTICALS INCORPORATED	-.--%	-.--%	-242.84x	7.567	10.63x	139.98x	189.54x	124B
REGENERON PHARMACEUTICALS, INC.	-.--%	-.--%	30.78x	4.235	8.09x	19.73x	21.65x	124B
ARGENX SE	-.--%	-.--%	-523.11x	7.314	14.38x	-174.63x	-165.56x	32.04B
BIONTECH SE	-.--%	-.--%	-46.23x	1.369	5.25x	-14.87x	-11.92x	29.65B
BEIGENE, LTD.	-.--%	-.--%	-32.43x	6.299	5.33x	-32.76x	-27.14x	21B
GENMAB A/S	-.--%	-.--%	21.51x	3.396	4.24x	13.88x	14.57x	16.8B
WUXI APPTEC CO., LTD.	+2.42%	+2.62%	12.12x	1.882	2.58x	7.29x	8.82x	16.04B
VAXCYTE, INC.	-.--%	-.--%	-26.05x	-	-	-	-	14.44B
INSMED INCORPORATED	-.--%	-.--%	-14.1x	-57.197700	36.81x	-17.17x	-16.6x	12.59B
NEUROCRINE BIOSCIENCES, INC.	-.--%	-.--%	28.59x	4.370	4.47x	16.54x	16.81x	12.35B
SAREPTA THERAPEUTICS, INC.	-.--%	-.--%	67.7x	9.562	6.47x	78.85x	99.39x	11.99B
ZEALAND PHARMA A/S	-.--%	-.--%	-81.12x	6.678	120.16x	-86.34x	-69.48x	9.68B
LEGEND BIOTECH CORPORATION	-.--%	-.--%	-43.43x	9.850	15.29x	-30.11x	-26.47x	9.37B
ASCENDIS PHARMA A/S	-.--%	-.--%	-19.14x	1,465.09	25.24x	-23.44x	-23.09x	8.41B
AKESO, INC.	-.--%	-.--%	-153.44x	11.94	22.66x	-371.53x	-148.19x	8.02B
EXELIXIS, INC.	-.--%	-.--%	17.8x	3.262	3.33x	11.95x	13.23x	7.87B
Average	+0.15%	+0.16%	-62.71x	99.04	19.00x	-30.84x	-8.30x	28.64B
Weighted average by Cap.	+0.08%	+0.09%	-101.35x	31.55	12.36x	22.95x	43.65x